JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linkenheimer, W. H.
Right arrow Articles by Wozniak, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linkenheimer, W. H.
Right arrow Articles by Wozniak, L. A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 149, Issue 2, 280-287, 1965
Copyright © 1965 by American Society for Pharmacology and Experimental Therapeutics


THE PHARMACOLOGY OF SULFAETHOXYPYRIDAZINE IN THE HEIFER

W. H. Linkenheimer 1, S. J. Stolzenberg 1, and L. A. Wozniak 1

1 Agricultural Division, American Cyanamid Company, Princeton, New Jersey

Heifers were treated with a single dose (25 mg/lb body weight) of sulfaethoxypyridazine by intravenous and oral routes. Concentrations of sulfonamide as total, free, and polar metabolite or "glucuronide" were measured in plasma and urine samples. Persistent plasma levels were maintained. A plasma half-life of 10 hours was calculated from the intravenous data. The parent sulfonamide was bound to plasma proteins to the extent of 96 to 90% at concentrations of 5 to 10 mg %. Cumulative urinary excretion of sulfonamide accounted for 62% of the intravenous dose and 63% of the oral dose at 72 hours. Ethyl acetate extraction, paper strip and column chromatography techniques showed that of the sulfonamide in the plasma, 10% was the N4 acetyl conjugate, 87% as unchanged sulfaethoxypyridazine, and 3% as possibly a glucuronide. In the urine, 84% was the N4 acetylated derivative, 9.5% was sulfaethoxy-pyridazine, and 6.5% was the unidentified glucuronide. Two other minor sulfonamide components, found only in the urine, appear to be formed in vitro.

Accepted on March 22, 1965







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1965 by the American Society for Pharmacology and Experimental Therapeutics.